![]() | ![]() |
Formats:
|
||||||||||||||||||||
Copyright © 2009 by Cold Spring Harbor Laboratory Press Yeast Mph1 helicase dissociates Rad51-made D-loops: implications for crossover control in mitotic recombination 1Department of Molecular Biophysics and Biochemistry, Yale University School of Medicine, New Haven, Connecticut 06520, USA 2Baylor College of Medicine, Department of Molecular and Human Genetics One Baylor Plaza, Houston, Texas 77030, USA 3Institute for Microbiology and Genetics, University of Göttingen, Department of Molecular Genetics and Preparative Molecular Biology, D-37077 Göttingen, Germany 4National Center for Biomolecular Research, Masaryk University, Brno 62500, Czech Republic 5Department of Biochemistry and Kaplan Cancer Center, New York University School of Medicine, New York, New York 10016, USA 6Rosenstiel Center and Department of Biology, Brandeis University, Waltham, Massachusetts 02454, USA 7These authors contributed equally to this work 8Present address: Institute of Biochemistry, Medical Faculty, Christian Albrecht, University Kiel, Olshausenstrasse 40, D-24098 Kiel, Germany 9Corresponding authors.E-MAIL gira/at/bcm.edu; FAX (713) 798-8967. 10E-MAIL patrick.sung/at/yale.edu.; FAX (203) 785 6037. Received September 8, 2008; Accepted November 12, 2008. This article has been cited by other articles in PMC.Abstract Eukaryotes possess mechanisms to limit crossing over during homologous recombination, thus avoiding possible chromosomal rearrangements. We show here that budding yeast Mph1, an ortholog of human FancM helicase, utilizes its helicase activity to suppress spontaneous unequal sister chromatid exchanges and DNA double-strand break-induced chromosome crossovers. Since the efficiency and kinetics of break repair are unaffected, Mph1 appears to channel repair intermediates into a noncrossover pathway. Importantly, Mph1 works independently of two other helicases—Srs2 and Sgs1—that also attenuate crossing over. By chromatin immunoprecipitation, we find targeting of Mph1 to double-strand breaks in cells. Purified Mph1 binds D-loop structures and is particularly adept at unwinding these structures. Importantly, Mph1, but not a helicase-defective variant, dissociates Rad51-made D-loops. Overall, the results from our analyses suggest a new role of Mph1 in promoting the noncrossover repair of DNA double-strand breaks. Keywords: Genome instability, recombination, DNA helicase, crossing over, Fanconi anemia DNA double-strand breaks (DSBs) that arise during DNA replication or are induced by DNA damaging agents, such as ionizing radiation, are frequently repaired by homologous recombination (HR). In yeast and other eukaryotes, the RAD52 epistasis group of proteins mediate homologous recombination (for reviews, see Paques and Haber 1999; Krogh and Symington 2004). In this process, DSB ends are resected by nucleases to create 3′ ssDNA that becomes coated with the recombinase protein Rad51. The Rad51–ssDNA nucleoprotein filament then carries out a search for a homologous donor DNA sequence and promotes strand invasion of the donor molecule to form a D-loop (Sung and Klein 2006). After D-loop formation, there appear to be two alternative pathways that result in DSB repair. One pathway involves the formation of a double Holliday junction (dHJ) that can be resolved by symmetrical strand cleavage into either a crossover or noncrossover gene conversion (Szostak et al. 1983). An alternative mechanism, called synthesis-dependent strand annealing (SDSA), posits formation mostly of noncrossovers, and in most cases does not involve a dHJ intermediate (for review, see Paques and Haber 1999). In support of the SDSA model of gene conversion, we showed recently that both newly synthesized strands are inherited by the broken recipient DNA molecule (Ira et al. 2006). The choice between crossover and noncrossover is tightly regulated in both mitotic and meiotic cells. In meiotic S. cerevisiae cells the correct number of crossovers are required for proper chromosome segregation; the proportion of gene conversion accompanied by crossing over varies between 25% and 50% depending on the locus (Roeder 1995). In mitotic cells, the proportion of crossovers is much lower, ranging between <1% and 15%, depending on the recombination assay and organism (Esposito 1978; Nassif et al. 1994; Johnson and Jasin 2000; Virgin et al. 2001; Stark and Jasin 2003). These differences are best explained if recombination proceeds most often according to the dHJ model in meiotic cells and via SDSA and other noncrossover means in mitotic cells. However, even in meiotic cells SDSA model explains best at least a part of noncrossover products (McMahill et al. 2007). The suppression of mitotic crossovers, which can lead to gross chromosome aberrations and rearrangements, is thought to be critical for the preservation of genome integrity (Richardson et al. 1998; Shaw and Lupski 2004). In both mitotic and meiotic Saccharomyces cells, crossover and noncrossover products are generated by genetically and kinetically distinct pathways (Allers and Lichten 2001; Hunter and Kleckner 2001; Ira et al. 2003; Barbera and Petes 2006; McMahill et al. 2007). Crossover and noncrossover pathways have different genetic requirements in mammalian cells as well (Guillon et al. 2005). In yeast mitotic cells, we and others demonstrated that two DNA helicases, Sgs1 and Srs2, suppress crossovers in DSB-induced and spontaneous recombination, but in different ways (Ira et al. 2003; Lo et al. 2006; Robert et al. 2006). Sgs1 was also shown to suppress crossing over in the meiotic cycle, particularly when three or four chromatids are involved in recombination (Jessop et al. 2006; Oh et al. 2007, 2008; Jessop and Lichten 2008). Srs2 appears to promote steps in the SDSA pathway, whereas Sgs1 and its associated topoisomerase Top3 reduce crossovers apparently by resolving the dHJ in a noncrossover manner. The postulated role of Sgs1–Top3 is strongly supported by biochemical data showing that the human ortholog of Sgs1/Top3, BLM/Topo IIIα, is able to dissolve dHJs to yield noncrossovers (Wu and Hickson 2003). RECQ5, a homolog of the BLM helicase, is involved in the suppression of crossing over (Wang et al. 2003; Hu et al. 2005). By exploiting published information regarding the synthetic lethal growth phenotypes of srs2 with other mutations (Tong et al. 2004), we sought to identify novel yeast genes that specifically affect the proportion of crossover outcome. Among synthetic interactors with srs2Δ in yeast and its Escherichia coli homolog uvrD there are a number of genes encoding proteins working in later steps of recombination including Sgs1–Top3 and Rad54 in yeast and the ruvABC resolvase in E. coli (Palladino and Klein 1992; Stewart et al. 1997; Gangloff et al. 2000; Solinger and Heyer 2001; Solinger et al. 2002; Bugreev et al. 2006; Magner et al. 2007). It has been hypothesized that in the absence of the anti-recombinase Srs2/uvrD (Krejci et al. 2003; Veaute et al. 2003) and enzymes that resolve recombination intermediates, toxic intermediates accumulate to cause cell death (Gangloff et al. 2000; Fabre et al. 2002; Magner et al. 2007). Therefore, we presumed that it would be possible to identify novel proteins involved in late stages of recombination that direct DSB repair toward crossover or noncrossover by screening all SRS2 synthetic interactors.We deleted the yeast genes previously demonstrated to have synthetic interaction with srs2Δ (Tong et al. 2004) in a strain with which we could follow the frequency of crossovers and noncrossovers accompanying the repair of an HO endonuclease-induced DSB. We found that only the deletion of MPH1 or RMI1 leads to an increase in the frequency of crossing over. Deletion of RMI1 causes a twofold increase in crossover frequency, and this phenotype is epistatic to sgs1Δ, consistent with the premise that Rmi1 influences the dHJ dissolution activity of the Sgs1–Topo IIIα complex (Wu and Hickson 2003; Chang et al. 2005; Mullen et al. 2005). The absence of the Mph1 helicase, yeast's ortholog of the Fanconi anemia (FA) protein FANCM, elevates crossover frequency by more than threefold. Importantly, this crossover regulatory role of Mph1 is independent of Sgs1 and Srs2. Mph1, like Sgs1, suppresses spontaneous unequal sister chromatid exchange as well. We present chromatin immunoprecipitation (ChIP) and biochemical data to implicate Mph1 in the dissociation of the Rad51-made D-loop intermediate. These results implicate Mph1 in channeling recombination intermediates into the noncrossover pathway(s), and have implications as to an analogous role of the human FANCM protein. Results Mph1 and Rmi1/Nce4 promote noncrossover outcomes in mitotic cells To identify proteins involved in post-synaptic stages of recombination we examined genes (CHL1, RMI1/NCE4, MPH1, ESC2, RRM3, RTT107, RTT106, MMS1, MGS1, RAD27, MRC1, CSM3, HEX3, HST3, CTK1, and ELG1) whose deletion shows a negative synthetic interaction with srs2Δ (Tong et al. 2004) for their possible role in the regulation of crossover formation in mitotic cells. SGS1–TOP3 and MUS81–MMS4 have been tested previously (Ira et al. 2003). RAD54 was not tested here because it is required for all gene conversion (Sugawara et al. 2003). We used an ectopic recombination system where the DSB created by HO endonuclease within a MAT
a sequence on chromosome V is repaired by HR with MAT
a-inc sequences on chromosome III (Fig. 1A
We measured the frequency of crossovers among the recombination products 8 h after HO induction, the time when most cells have already completed repair (Ira et al. 2003). The crossover frequency was determined in Southern blots as a ratio of the intensity of the band corresponding to gene conversion with crossing over to the intensity of bands corresponding to gene conversions both with and without a crossover. Viability was determined as a ratio of the number of cells on YEP medium with galactose (HO break induction) to the number of cells on YEP with dextrose (no DSB). Among all tested genes only the deletion of MPH1 (tGI772) or RMI1/NCE4 (tGI853) showed a marked change in crossover frequency: mph1Δ cells had 18% crossovers (a more than threefold increase compared with wild type), while the rmi1Δ/nce4Δ deletion doubled the level of crossovers (Fig. 1B
Mph1 regulates crossovers in allelic and sister chromatid recombination To ask whether the effect of mph1Δ on crossovers is specific to ectopic recombination, where homologous sequences are limited to about 2 kb, we tested the impact of Mph1 on crossovers in allelic recombination in a diploid strain where there is essentially unlimited homology on both sides of the DSB (Supplemental Fig. S1). The HO break was induced on one chromosome III, while the donor chromosome III carried a single base pair mutation within the HO recognition site. The frequency of crossovers was scored as the number of reciprocal sectors involving the distal markers THR4 and thr4ΔrURA3 (16 kb away from HO break). Wild-type cells showed 13% ± 2% crossovers, while mph1/mph1 cells exhibited 29% ± 4% crossing over; the overall repair efficiency was not changed (Supplemental Fig. S1). Therefore, the effect of Mph1 helicase on gene conversion is not limited to ectopic recombination. In the same assay, srs2Δ and sgs1Δ diploids increase the frequency of crossovers by twofold to threefold with no change in the efficiency of DSB repair (Ira et al. 2003; Lo et al. 2006). A high level of intersister chromatid exchanges is a hallmark of Bloom syndrome cells (Chaganti et al. 1974) and of mutants, such as sgs1 , deficient in the BLM ortholog (Onoda et al. 2004). We examined the frequency of sister chromatid exchanges in mph1Δ cells in a system where recombination between sister chromatids carrying direct truncated his3 repeats, his3-Δ5′ and his3-Δ3′, gives His+ colonies (Fasullo and Davis 1987). The results showed that mph1Δ cells (yGI012) have a 2.5-fold increase (3.0 ± 0.3 × 10−6) of unequal intersister exchanges per cell division when compared with wild-type cells (yNN301; 1.2 ± 0.5 × 10−6). In conclusion, Mph1 appears to be a general crossing-over suppressor in mitotic recombination.Helicase activity of Mph1 is required for crossover suppression Mph1 is a member of the DEAH family of helicases (Scheller et al. 2000). To test whether the function of Mph1 in HR depends on its helicase domains, we quantified crossovers in mph1Δ mutant cells transformed with multicopy 2-μm plasmids (pYES2) carrying either the wild-type MPH1 gene (yDS024) or five different MPH1 alleles with mutations in the conserved helicase motifs—I (K113Q), II (D209N, E210Q, and H212D), and IV (Q603D)—predicted to impair the helicase activity (strains yDS018–22). Consistent with this premise, one of these mutants, D209N, was expressed in yeast cells, purified, and shown to lack both ATPase and helicase activities (Supplemental Fig. 4). Suppression of the high-crossover phenotype was observed for the wild-type MPH1 gene only (Fig. 2C Mph1 suppresses crossovers independently of Sgs1 and Srs2 The single sgs1Δ and srs2Δ mutants elevate the frequency of crossovers from 5% to 12% and 17%, respectively. The double mutant mph1Δ sgs1Δ (tGI787), which grows well, shows 32% crossing over among the products with no decrease in DSB repair compared with wild type (Fig. 3A with either sgs1 or srs2 is slightly more than additive could mean that these helicases also fulfill partially overlapping roles.
Mph1 is recruited to DSBs We used ChIP to examine whether Mph1 is recruited to the HO break. For this purpose, we constructed TAP-tagged Mph1 strains in backgrounds that harbor or lack the HML donor sequence. The tagged strains are just as resistant to the genotoxin MMS as the untagged counterpart (data not shown), thus verifying that affinity tagging has no adverse effect on the biological activity of Mph1. At various times after HO induction, an aliquot of the yeast cultures was processed for ChIP, using IgG Sepharose beads to precipitate TAP-tagged Mph1 and associated DNA. Radioactive PCR with the appropriate primer sets was then used to amplify the target sequences: MAT Z (the invading strand) and HMLα (the recombination donor) (Wolner et al. 2003; Kwon et al. 2008). As shown in Figure 3B Mph1 binds and unwinds D-loops We used a DNA mobility shift assay with radiolabeled DNA substrates to investigate whether purified Mph1 protein (Prakash et al. 2005) has affinity for various DNA structures, including the D-loop and the HJ that are generated during recombination. In these experiments, we incubated Mph1 with both the D-loop substrate containing a 5′ tail and one of the remaining DNA substrates, dsDNA, ssDNA, DNA bubble, and the HJ. At low stringency (50 mM KCl), Mph1 shows a significant preference for D-loop over HJ (Supplemental Fig. 2B), ssDNA or dsDNA (Fig. 4B
We next asked whether Mph1 can dissociate D-loops (with no overhang, a 3′ overhang, or a 5′ overhang), a DNA bubble, and a HJ. The results showed that Mph1 unwinds the three D-loop substrates with the same efficiency (Fig. 4C Effect of Mph1 on the Rad51-catalyzed D-loop reaction During recombination, a nucleoprotein complex of Rad51 and ssDNA invades a homologous duplex molecule to produce a D-loop intermediate (San Filippo et al. 2008). Since Mph1 binds and unwinds D-loop structures (Fig. 4
To ascertain the relevance of the Mph1 helicase activity in the attenuation of D-loop formation, we expressed the biologically inactive mph1 D209N mutant protein (Supplemental Fig. 4A), predicted to be deficient in ATPase and helicase activities, in yeast cells. Using the procedure that we originally devised for wild-type Mph1 (Prakash et al. 2005), the mph1 D209N protein was purified to near homogeneity (Supplemental Fig. 4B). During purification, the mph1 D209N mutant protein behaved exactly like the wild-type protein and a yield of the mutant similar to that of wild-type protein was obtained (data not shown). As expected, the mph1 D209N protein is devoid of the ability to hydrolyze ATP or to unwind DNA (Supplemental Fig. 4C,D) but proficient in DNA binding (Supplemental Fig. 5E). Importantly, the inclusion of as much as 200 nM of the mutant mph1 D209N protein has little or no effect on the Rad51-mediated D-loop reaction (Fig. 5C Mechanism of Mph1 action The reduction of D-loop formation in prior experiments could have arisen because of Mph1’s ability to dissociate the D-loop or an ability of Mph1 to disrupt the Rad51 presynaptic filament. A variety of biochemical and electron microscopic analyses were performed to help distinguish between these possibilities. We first carried out order of addition of experiments in which Mph1 or the Srs2 helicase was incorporated either at the beginning of the D-loop reaction or after the D-loop had already been made. Consistent with its Rad51 filament disruptive function (Krejci et al. 2003; Veaute et al. 2003), Srs2 strongly attenuates the D-loop reaction when added with Rad51 to the ssDNA but seems incapable of dissociating the D-loop product (Fig. 7A
Further details regarding Mph1's action mechanism were revealed by conducting detailed time course experiments with substrates that yield D-loops with no overhang, a 3′ overhang, or a 5′ overhang. In the absence of Mph1, the D-loop product reaches its maximal level after 1 min of incubation. The inclusion of Mph1 does not seem to prevent D-loop formation, but rather leads to a gradual disappearance of the D-loop product, such that slightly less D-loop product is seen at the earlier time points (e.g., 1 min) and little D-loop is left after 8 min (Fig. 6C–F The conclusion that Mph1 does not significantly affect the integrity of the Rad51–ssDNA nucleoprotein filament was validated biochemically and also by electron microscopy. In the biochemical experiment, preassembled Rad51–ssDNA nucleoprotein filaments were incubated with Mph1 or Srs2 in the presence of RPA, followed by the addition of topologically relaxed DNA to trap the displaced Rad51 molecules. The binding of Rad51 to the relaxed DNA trap induced positive DNA supercoiling, which was removed by calf thymus topoisomerase I to result in the generation of an unwound DNA species, called Form U, upon deproteinization of the reaction mixture (see Supplemental Fig. 5A for schematic). The results showed that, unlike Srs2, Mph1 does not appear to be capable of dismantling the Rad51–ssDNA nucleoprotein filament (Supplemental Fig. 5A). Finally, electron microscopy was used to quantify the dissociation of Rad51–ssDNA nucleoprotein filaments. As reported previously (Krejci et al. 2003; Veaute et al. 2003) and confirmed here, the incubation of preformed Rad51–ssDNA nucleoprotein filaments with Srs2 and RPA led to an efficient exchange of these filaments by RPA–ssDNA complexes (Supplemental Fig. 5B). In contrast, Mph1 had little or no impact on the level of Rad51–ssDNA nucleoprotein filaments (Supplemental Fig. 5B). Overall, the results support the idea that Mph1’s regulatory action in recombination is related to its ability to dissociate the D-loop intermediate made by Rad51 protein. We propose that this Mph1 activity is important for promoting the noncrossover pathway of recombination. Comparison of D-loop disrupting activity of Mph1 and RecQ-like helicases The RecQ-like helicases BLM and WRN can unwind the D-loop structure (van Brabant and Holloman 2000; Orren et al. 2002). Moreover, RECQ1 and BLM have been found to dissociate D-loops made by the human Rad51 protein under specific reaction conditions (Bugreev et al. 2007, 2008). However, within the protein concentration range where Mph1 exerts a strong negative effect on the yeast Rad51-mediated D-loop reaction, none of RECQ1, BLM, and WRN noticeably influences the reaction efficiency (data not shown). As shown in Figure 7B Discussion Mph1 is an ATP-dependent helicase with 3′–5′ polarity (Prakash et al. 2005), which was initially identified in a screen for mutants with increased spontaneous mutation rate as measured by the formation of canavanine resistant colonies (Entian et al. 1999). Based on the epistatic relationship of MPH1 and RAD51 with respect to canavanine reversion rate and MMS damage sensitivity, Schürer et al. (2004) proposed that Mph1 functions in one of several HR pathways. To understand the action mechanism of Mph1, we carried out genetic studies to unveil a major regulatory role of this helicase in DSB repair by promoting noncrossover formation. Other helicases, RecQ homologs and Srs2, also suppress crossovers associated with gene conversion. Mechanistically, the human BLM helicase works together with topoisomerase IIIα and the BLAP75/Rmi1 protein to branch migrate and decatenate dHJs into noncrossovers (Wu and Hickson 2003; Raynard et al. 2006; Wu et al. 2006). It is expected that Sgs1, the likely BLM ortholog in Saccharomyces cerevisiae, also functions in this manner to resolve dHJs into noncrossover during DSB repair. Thus, BLM and Sgs1 act late in the regulation of recombination outcome, to direct the resolution of the dHJ structure formed via second DNA end capture to yield noncrossovers (Fig. 8
Since Mph1 influences the outcome rather than the efficiency of recombinational repair events, it very likely acts by shunting a DNA intermediate into the SDSA pathway. As revealed in ChIP experiments, Mph1 is targeted to DSBs in cells, suggesting that its action in recombination regulation is direct. Our biochemical results provided evidence that Mph1 regulates recombination pathway choice by dissociating the invading DNA strand from the Rad51-made D-loop (Fig. 7 It is not clear whether the hypermutable phenotype of mph1 mutants (Entian et al. 1999; Schürer et al. 2004) is related to the ability of the Mph1 helicase to dissociate Rad51-made D-loops. The Sgs1 helicase plays distinct roles in DSB end resection (Gravel et al. 2008; Mimitou and Symington 2008; Zhu et al. 2008), the DNA replication checkpoint (Frei and Gasser 2000), the control of homeologous recombination (Myung et al. 1999), and in recombination regulation via DNA branch migration (Karow et al. 2000) and dHJ dissolution (Wu and Hickson 2003). Given this, it seems reasonable to consider the possibility that Mph1’s involvement in mutation avoidance is unrelated to its D-loop dissociative function. Likely orthologs of Mph1 have been identified across many species including humans. The best characterized is archaeal Hef helicase from Pyrococcus furiosus. Hef protein, in addition to its helicase domain, also carries an endonuclease domain similar to Mus81 and Rad1/XPF nucleases (Komori et al. 2002, 2004). Recently, a human homolog of Mph1, FANCM, was identified as a part of the FA core complex 1 (Meetei et al. 2005; Mosedale et al. 2005). Initial studies suggested that FANCM protein does not have DNA unwinding activity; however, its helicase domains are required for DNA damage resistance (Xue et al. 2008). The function of the FA pathway, comprising at least 12 proteins, remains unclear. Based on the finding that BRCA2, a key protein in recombination, and FANCJ (also known as BACH or BRIP), a DNA helicase that interacts with BRCA1, are components of the FA pathway, a role of this pathway in HR has been proposed (Howlett et al. 2002; Bridge et al. 2005; Litman et al. 2005). Whether the FA pathway plays a regulatory role in HR or constitutes a subpathway of HR is not known. Here we demonstrate a very specific role for yeast's FANCM homolog in suppressing crossovers associated with DSB-induced gene conversion. The possibility that FA proteins are involved in post-synaptic stages of recombination like Mph1 is supported by the interaction of Fanconi proteins and proteins involved in the resolution of HJs, BLM and XRCC3 (Wu and Hickson 2003; Liu et al. 2004; Pichierri et al. 2004; Hussain et al. 2006). Finally, similar to the yeast mph1Δ mutant, chicken DT40 cells deficient in FANCC, FANCD2, or FANCJ also show increased SCEs (Niedzwiedz et al. 2004; Bridge et al. 2005; Hirano et al. 2005; Yamamoto et al. 2005). Crossovers are potentially dangerous, and occur much less frequently in mitotic than meiotic cells (Esposito 1978; Nassif et al. 1994; Johnson and Jasin 2000; Virgin et al. 2001; Stark and Jasin 2003). Specifically, crossovers may lead to loss of heterozygosity (Beumer et al. 1998) and can result in chromosomal aberrations such as translocations, inversions, or deletions. Indeed, crossovers between low-copy repeats may account for many human disorders (for review, see Shaw and Lupski 2004). Now the means by which the low proportion of exchanges is achieved becomes evident with the demonstration that three different helicases, Sgs1/Rmi1/Top3, Srs2, and Mph1, act in apparently unique and independent ways to suppress crossover formation. Materials and methods Yeast strains and plasmids All yeast strain used in this study are listed in Supplemental Table 1. Yeast strains used in this study for mitotic crossover analysis are derivatives of tGI354 (Δho Δhml ADE1 MATa-inc Δhmr ADE1 ade1 leu2-3,112 lys5 trp1 hisG ura3-52 ade3 GAL HO arg5,6 GAL MATa). All Mph1 overexpression plasmids were constructed in 2 μ vector pYES2, where MPH1 is under the control of the GAL1 promoter.Analysis of crossover frequency and DSB repair kinetics The crossover frequency among recombination products in the ectopic recombination assay was determined as a ratio of the intensity of the band corresponding to gene conversion with crossover to the intensity of bands corresponding to gene conversion both with and without crossover. We measured the frequency of crossovers among the recombination products 8 h after HO induction. DNA isolated from cells was digested with EcoRI enzyme and separated on 0.8% agarose gel. DNA was transferred to Nylon+ membrane and hybridized with a MAT
a probe corresponding to 200 base pairs (bp) on each side of HO cut site. To calculate kinetics of repair we normalized the DNA amount using DNA probe specific for APA1 gene. Unequal sister chromatid exchange Unequal SCE was measured using a system described by Fasullo and Davis (1987). The rates of spontaneous mitotic SCE were determined by the method of median using 11 independent colonies for each rate calculation. At least three independent rate calculations were done for each strain and significance of the differences was calculated by the Mann-Whitney U-test (Zarr 1999). Viability The viability of mutants after HO-induced DSB breakage was calculated as a ratio of the number of cells on YEP with galactose (HO break induction) to the number of cells on YEP with dextrose (no DSB break). ChIP assay The donorless yeast strain used in this study was derived the strain JKM179. The strain capable of undergoing DSB-induced gene conversion was derived from JKM161 (see Supplemental Table 1). Both strains harbor the HO gene under the control of the galactose inducible GAL10 promoter. A TAP epitope was attached at the C terminus of the chromosomal MPH1 gene to facilitate Mph1 immunoprecipitation. The expression of TAP-tagged Mph1 in these strains was verified by Western blotting with polyclonal antibodies raised against purified Mph1. To perform ChIP assays, cells were grown in YP media containing 3% glycerol until they reached mid-log phase, followed by the addition of galactose (2%) to induce the HO endonuclease. At the designated times, 45-mL cell aliquots were taken, treated with formaldehyde (1%) for 20 min, and then quenched with 125 mM glycine for 5 min. Cell lysates were prepared and incubated with IgG Sepharose beads for 2 h (Amersham Biosciences). The beads were washed extensively, followed by incubation for 6 h at 65°C to reverse protein–DNA cross-links. Radioactive semiquantitative PCR was used to amplify the MAT Z or HMLα locus and the PHO5 sequence, which was included as the internal control (Wolner et al. 2003). The PCR reaction mixtures were resolved in a 6% nondenaturing polyacrylamide gel run in TBE buffer (40 mM Tris borate at pH 7.4, 0.5 mM EDTA) and quantified by phosphorimaging analysis. The MAT Z or HMLα signal at each time point was divided by the corresponding PHO5 signal and normalized to the 0-h time-point signal, as described (Wolner et al. 2003; Kwon et al. 2008). Expression and purification of the mph1 D209N protein The D209N mutation was introduced into Mph1 using the QuickChange Site-Directed Mutagenesis kit (Stratagene) and pYES2-Mph1 (2μ, URA3, and GAL1-MPH1) (Prakash et al. 2005) as the template. The protein expression plasmid pYES2-mph1 D209N was maintained in the protease-deficient strain BJ5464 (Supplemental Table 1), and protein expression was induced by galactose addition. The mutant mph1 protein was purified to near homogeneity as described previously for the wild-type counterpart (Prakash et al. 2005). Purification of other proteins Yeast Rad51 protein and BLM helicase were purified from yeast cells tailored to express them, as described (Sung and Stratton 1996; Raynard et al. 2006), and WRN helicase was purified from HighFive insect cells infected with a recombinant bacculovirus that expresses it, as described (Brosh et al. 2000; Raynard et al. 2006). Yeast Rad54 protein, Srs2 helicase, RECQ1 helicase, human Hop2–Mnd1 complex, and yeast and human RPA were purified to near homogeneity from E. coli cells tailored to express them, as described (Sigurdsson et al. 2001; Krejci et al. 2003; Cui et al. 2004; Van Komen et al. 2006; Chi et al. 2007). The BLM, RECQ1, and WRN helicase preparations have been used in several of our published studies (e.g., Raynard et al. 2006; Hu et al. 2007) and they possess a level of DNA-dependent ATPase activity as high as or higher than that reported in the literature (Brosh et al. 1999, 2000; Cui et al. 2004; data not shown) and, as expected (Brosh et al. 1999, 2000; Cui et al. 2004), are adept at unwinding a HJ test substrate (Supplemental Fig. 6). DNA substrates The oligonucleotides (Integrated DNA Technology) used in this study for DNA-binding and helicase assays are listed in Supplemental Table 2. To construct the DNA substrates, selected gel-purified oligonucleotides were 5′ end-labeled with [γ-32P] ATP using T4 polynucleotide kinase and then annealed to their partner oligonucleotides by heating an equimolar amount of the oligonucleotides at 95°C for 10 min in buffer H (50 mM Tris-HCl at pH 7.5, 10 mM MgCl2, 100 mM NaCl) and slow cooling to room temperature. Hybridized DNA substrates were separated from unannealed oligonucleotides in a 5% nondenaturing polyacrylamide gel run in TBE buffer and recovered from the gel by electroelution in dialysis tubing in TBE buffer at 4°C. The structure of the DNA substrates used in this study can be found in individual figures and their legends, and the sequence of these oligonucleotide is provided in Supplemental Table 2. DNA helicase assay The indicated concentration of Mph1 or mph1 D209N protein was incubated at 30°C with the radiolabeled DNA substrate (50 nM) in 15 μL of buffer R (30 mM Tris-HCl at pH 7.5, 1 mM DTT, 100 μg/mL BSA) containing 2.5 mM MgCl2, 2 mM ATP, and 50 mM KCl. The reaction was stopped after 10 min by treatment with SDS (0.2% final) and proteinase K (0.5 mg/mL) for 2 min at 30°C. The reaction mixtures were resolved in a 10% polyacrylamide gel in TAE buffer at 4°C. Gels were dried onto Whatman DE81 paper (Whatman International Limited) and then analyzed in a Personal Molecular Imager FX PhosphorImager (Bio-Rad). DNA mobility shift assay The indicated concentration of Mph1 or mph1 D209N was incubated with the radiolabeled DNA substrate (50 nM) at 30°C in 10 μL of buffer R containing 50 mM KCl for 5 min. After the addition of 2 μL of gel loading buffer (50% glycerol, 20 mM Tris-HCl at pH 7.4, 2 mM EDTA, 0.05% orange G), the reaction mixtures were resolved in a 5% polyacrylamide gel in TAE buffer. Gels were dried and subjected to phosphorimaging analysis as above. Where indicated, reaction mixtures were treated with 0.5% SDS and 0.5 mg/mL proteinase K (SDS/PK) at 37°C for 3 min before electrophoresis. D-loop reaction mediated by yeast or human Rad51 protein The reaction (final volume of 12.5 μL) was performed in Buffer R containing 2.5 mM MgCl2, 2.0 mM ATP, 50 mM KCl, and an ATP-regenerating system consisting of 20 mM creatine phosphate and 20 μg/mL creatine kinase. The indicated radiolabeled oligonucleotide (2.4 μM nucleotides D1 or 3.72 μM nucleotides D2 or D3) was incubated with yeast or human Rad51 (0.8 μM for Oligonucleotide D1 or 1.24 μM for Oligonucleotide D2 or D3) for 5 min at 37°C to assemble the Rad51–ssDNA nucleoprotein filament, followed by the incorporation of yeast Rad54 (150 nM, for yeast Rad51) or the human Hop2–Mnd1 complex (300 nM, for human Rad51) and yeast RPA (200 nM, for yeast Rad51) or human RPA (200 nM, for human Rad51) and a 2-min incubation at 23°C. The D-loop reaction was initiated by the addition of pBluescript replicative form I DNA (37 μM base pairs). The reaction mixtures were incubated at 30°C for the indicated times, deproteinized by treatment with SDS (0.5%) and proteinase K (0.5 mg/mL) at 37°C for 3 min, and then resolved in a 0.9% agarose gel in TAE buffer. Gels were dried onto Whatman DE81 paper and then analyzed in the phosphorimager. To test the effect of the DNA helicases on the D-loop reaction, they were incorporated into the reaction as indicated in each case. Acknowledgments We thank Ketan Patel, Wojciech Niedzwiedz, and Susan Rosenberg for sharing unpublished data; Steven Brill for strains; Marc Pypaert for guidance in the EM work; and Quiqin Wu for technical assistance. This project was supported by NIH grants GM80600, GM20056, ES07061, GM57814, and GM53738; Wellcome Trust grant GR076476; EMBO/HHMI start-up program ME888; and grant Kr 914/6-1 of the Deutsche Forschungsgemeinschaft. Footnotes Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.1737809. Supplemental material is available at http://www.genesdev.org. References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||||
Microbiol Mol Biol Rev. 1999 Jun; 63(2):349-404.
[Microbiol Mol Biol Rev. 1999]Annu Rev Genet. 2004; 38():233-71.
[Annu Rev Genet. 2004]Nat Rev Mol Cell Biol. 2006 Oct; 7(10):739-50.
[Nat Rev Mol Cell Biol. 2006]Cell. 1983 May; 33(1):25-35.
[Cell. 1983]Mol Cell Biol. 2006 Dec; 26(24):9424-9.
[Mol Cell Biol. 2006]Cell. 2001 Jul 13; 106(1):47-57.
[Cell. 2001]Cell. 2001 Jul 13; 106(1):59-70.
[Cell. 2001]Cell. 2003 Nov 14; 115(4):401-11.
[Cell. 2003]Proc Natl Acad Sci U S A. 2006 Aug 22; 103(34):12819-24.
[Proc Natl Acad Sci U S A. 2006]PLoS Biol. 2007 Nov 6; 5(11):e299.
[PLoS Biol. 2007]Science. 2004 Feb 6; 303(5659):808-13.
[Science. 2004]Genetics. 1992 Sep; 132(1):23-37.
[Genetics. 1992]EMBO J. 1997 May 15; 16(10):2682-92.
[EMBO J. 1997]Nat Genet. 2000 Jun; 25(2):192-4.
[Nat Genet. 2000]Proc Natl Acad Sci U S A. 2001 Jul 17; 98(15):8447-53.
[Proc Natl Acad Sci U S A. 2001]Science. 2004 Feb 6; 303(5659):808-13.
[Science. 2004]Nature. 2003 Dec 18; 426(6968):870-4.
[Nature. 2003]EMBO J. 2005 Jun 1; 24(11):2024-33.
[EMBO J. 2005]Mol Cell Biol. 2005 Jun; 25(11):4476-87.
[Mol Cell Biol. 2005]Science. 2004 Feb 6; 303(5659):808-13.
[Science. 2004]Cell. 2003 Nov 14; 115(4):401-11.
[Cell. 2003]Mol Cell. 2003 Jul; 12(1):209-19.
[Mol Cell. 2003]Cell. 2003 Nov 14; 115(4):401-11.
[Cell. 2003]Nat Genet. 2000 Jun; 25(2):192-4.
[Nat Genet. 2000]EMBO J. 2005 Jun 1; 24(11):2024-33.
[EMBO J. 2005]Mol Cell Biol. 2005 Jun; 25(11):4476-87.
[Mol Cell Biol. 2005]Cell. 2003 Nov 14; 115(4):401-11.
[Cell. 2003]Mol Cell Biol. 2006 Jun; 26(11):4086-94.
[Mol Cell Biol. 2006]Proc Natl Acad Sci U S A. 1974 Nov; 71(11):4508-12.
[Proc Natl Acad Sci U S A. 1974]DNA Repair (Amst). 2004 Oct 5; 3(10):1355-62.
[DNA Repair (Amst). 2004]Proc Natl Acad Sci U S A. 1987 Sep; 84(17):6215-9.
[Proc Natl Acad Sci U S A. 1987]Genetics. 2000 Jul; 155(3):1069-81.
[Genetics. 2000]Cell. 2003 Nov 14; 115(4):401-11.
[Cell. 2003]Mol Cell. 2003 Jul; 12(1):221-32.
[Mol Cell. 2003]J Biol Chem. 2008 Apr 18; 283(16):10445-52.
[J Biol Chem. 2008]J Biol Chem. 2005 Mar 4; 280(9):7854-60.
[J Biol Chem. 2005]Annu Rev Biochem. 2008; 77():229-57.
[Annu Rev Biochem. 2008]J Biol Chem. 2005 Mar 4; 280(9):7854-60.
[J Biol Chem. 2005]Nature. 2003 May 15; 423(6937):305-9.
[Nature. 2003]Nature. 2003 May 15; 423(6937):309-12.
[Nature. 2003]Nature. 2003 May 15; 423(6937):305-9.
[Nature. 2003]Nature. 2003 May 15; 423(6937):309-12.
[Nature. 2003]Biochemistry. 2000 Nov 28; 39(47):14617-25.
[Biochemistry. 2000]Biochemistry. 2002 Nov 19; 41(46):13483-8.
[Biochemistry. 2002]Genes Dev. 2007 Dec 1; 21(23):3085-94.
[Genes Dev. 2007]J Biol Chem. 2008 Jul 18; 283(29):20231-42.
[J Biol Chem. 2008]J Biol Chem. 2005 Mar 4; 280(9):7854-60.
[J Biol Chem. 2005]Mol Gen Genet. 1999 Dec; 262(4-5):683-702.
[Mol Gen Genet. 1999]Genetics. 2004 Apr; 166(4):1673-86.
[Genetics. 2004]Nature. 2003 Dec 18; 426(6968):870-4.
[Nature. 2003]J Biol Chem. 2006 May 19; 281(20):13861-4.
[J Biol Chem. 2006]Proc Natl Acad Sci U S A. 2006 Mar 14; 103(11):4068-73.
[Proc Natl Acad Sci U S A. 2006]Cell. 2003 Nov 14; 115(4):401-11.
[Cell. 2003]EMBO J. 2006 Jun 21; 25(12):2837-46.
[EMBO J. 2006]Genetics. 2004 Apr; 166(4):1673-86.
[Genetics. 2004]Mol Cell. 2008 Feb 1; 29(2):243-54.
[Mol Cell. 2008]Mol Gen Genet. 1999 Dec; 262(4-5):683-702.
[Mol Gen Genet. 1999]Genetics. 2004 Apr; 166(4):1673-86.
[Genetics. 2004]Genes Dev. 2008 Oct 15; 22(20):2767-72.
[Genes Dev. 2008]Nature. 2008 Oct 9; 455(7214):770-4.
[Nature. 2008]Cell. 2008 Sep 19; 134(6):981-94.
[Cell. 2008]Genes Genet Syst. 2002 Aug; 77(4):227-41.
[Genes Genet Syst. 2002]J Biol Chem. 2004 Dec 17; 279(51):53175-85.
[J Biol Chem. 2004]Nat Genet. 2005 Sep; 37(9):958-63.
[Nat Genet. 2005]Nat Struct Mol Biol. 2005 Sep; 12(9):763-71.
[Nat Struct Mol Biol. 2005]Hum Mol Genet. 2008 Jun 1; 17(11):1641-52.
[Hum Mol Genet. 2008]Science. 2002 Jul 26; 297(5581):606-9.
[Science. 2002]Nat Genet. 2005 Sep; 37(9):953-7.
[Nat Genet. 2005]Cancer Cell. 2005 Sep; 8(3):255-65.
[Cancer Cell. 2005]Nature. 2003 Dec 18; 426(6968):870-4.
[Nature. 2003]Science. 2004 Jan 9; 303(5655):243-6.
[Science. 2004]Proc Natl Acad Sci U S A. 1978 Sep; 75(9):4436-40.
[Proc Natl Acad Sci U S A. 1978]Mol Cell Biol. 1994 Mar; 14(3):1613-25.
[Mol Cell Biol. 1994]EMBO J. 2000 Jul 3; 19(13):3398-407.
[EMBO J. 2000]Genetics. 2001 Jan; 157(1):63-77.
[Genetics. 2001]Mol Cell Biol. 2003 Jan; 23(2):733-43.
[Mol Cell Biol. 2003]Proc Natl Acad Sci U S A. 1987 Sep; 84(17):6215-9.
[Proc Natl Acad Sci U S A. 1987]Mol Cell. 2003 Jul; 12(1):221-32.
[Mol Cell. 2003]J Biol Chem. 2008 Apr 18; 283(16):10445-52.
[J Biol Chem. 2008]J Biol Chem. 2005 Mar 4; 280(9):7854-60.
[J Biol Chem. 2005]J Biol Chem. 1996 Nov 8; 271(45):27983-6.
[J Biol Chem. 1996]J Biol Chem. 2006 May 19; 281(20):13861-4.
[J Biol Chem. 2006]J Biol Chem. 2000 Aug 4; 275(31):23500-8.
[J Biol Chem. 2000]J Biol Chem. 2001 Mar 23; 276(12):8798-806.
[J Biol Chem. 2001]Nature. 2003 May 15; 423(6937):305-9.
[Nature. 2003]